ArticleResearch square2021

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus.

Willis Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.